Analysis – Page 80 – Goldea Capital

V Gallant’s Fintech Partner Credilab Secures Full Online Lending Approval in Malaysia, Advancing Revenue-Share AI Lending Platform

Written by Customer Service on June 8, 2026. Posted in Public Companies.

Earlier-Quarter Partnership Positions V Gallant to Deploy AI Infrastructure and Automation Capabilities Across Digital Lending Operations KUALA LUMPUR, Malaysia, June 08, 2026 (GLOBE NEWSWIRE) — V Gallant Limited (“V Gallant”, or the “Company”), the AI and technology infrastructure arm of VCI Global Limited (NASDAQ: VCIG) (“VCI Global”), today announced that its fintech partner, Credilab Sdn Bhd (“Credilab”) has received approval to operate as a fully online lending platform in Malaysia. The approval advances the commercialization of V Gallant’s AI-powered lending infrastructure through an exclusive fintech AI automation partnership established earlier this quarter. Under the partnership, V Gallant will provide AI infrastructure, intelligent workflow automation, and operating-system capabilities to support Credilab’s...

Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today

Written by Customer Service on June 8, 2026. Posted in Public Companies.

As of June 4, 2026, based on the closing price of Fort common shares on the TSX Venture Exchange, Fort’s market capitalization was approximately US$46.4 million, Nexera to hold approximately 70.94% of the issued and outstanding common shares after trading on Nasdaq will commence Tel Aviv, Israel, June 08, 2026 (GLOBE NEWSWIRE) — Nexera Technologies Ltd (“Nexera” or the “Company”) (Nasdaq: NEXR, NEXRW), a data-driven company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”)-driven solutions, today announced that its majority-owned subsidiary, Fort Technology Inc. (TSXV: FORT) (NASDAQ: FRTT) (“Fort”), has received formal approval from the Nasdaq Stock Market LLC to list its common shares on the Nasdaq Capital Market (“Nasdaq”). The common shares...

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Written by Customer Service on June 8, 2026. Posted in Public Companies.

Company remains on track for a planned December 2026 evaluation of the clinical trial’s primary endpoint OCALA, Fla., June 08, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported positive progress in a mid-year update from the ongoing Phase 2 clinical study evaluating AIM’s drug Ampligen® (rintatolimod) combined with AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) in the treatment of metastatic pancreatic cancer patients with stable disease post-FOLFIRINOX standard of care (the “DURIPANC” study) (see: ClinicalTrials.gov NCT05927142). See: DURIPANC, 2026 Mid-Year Interim Clinical Progress Update AIM recently announced enrollment of the final patient in the clinical trial, barring any disqualifying pre-treatment circumstances. The Company remains on track...

Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security

Written by Customer Service on June 8, 2026. Posted in Public Companies.

The collaboration with VisionWave aims to deliver intelligent, real-time perception solutions for defense and security, with focus on counter-UAS and tactical unmanned systems NESS ZIONA, Israel, June 08, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced that it has entered into a definitive agreement with VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave”), a defense and advanced sensing technology company, for a strategic equity investment of up to $17.5 million, payable in shares of VisionWave’s common stock, reflecting a post investment valuation of approximately $34 million, for Foresight. The investment is intended to enhance Foresight’s perception technologies with advanced artificial intelligence (“AI”)...

Consolidated Water Appoints Water Industry Veteran Sachin Chawla as Senior Vice President, Strategy and Growth

Written by Customer Service on June 8, 2026. Posted in Public Companies.

GEORGE TOWN, Cayman Islands, June 08, 2026 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water treatment plants, has appointed Sachin Chawla to the new position of senior vice president, strategy and growth. He will direct and manage the company’s business development, sales and marketing activities, while helping the CEO advance M&A and broader business growth initiatives in support of the company’s strategic growth plan. “Sachin brings to Consolidated Water more than 25 years of water industry leadership experience spanning public and private sector businesses,” said Consolidated Water CEO Rick McTaggart. “His background in large-scale desalination projects, public utility operations and complex project development will help us broaden...

Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

Written by Customer Service on June 8, 2026. Posted in Public Companies.

First regulatory approval for Sjögren’s disease (SjD) First and only approved therapy for SjD in China Approval based on positive Phase 3 results generated by collaborator RemeGen demonstrating statistically significant and clinically meaningful improvements in both ESSDAI and ESSPRI SjD marks the fifth indication approval for telitacicept BOSTON, June 08, 2026 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, and RemeGen Co., Ltd., (HKEX: 9995, SHA: 688331) today announced that China’s National Medicinal Products Administration (NMPA) has approved telitacicept for the treatment of adult patients with SjD. The approval is supported by positive efficacy and safety data from RemeGen’s Phase 3 clinical program in Sjögren’s disease. RemeGen...

Orion Announces Multimillion-Dollar Data Center Engagement to Deploy LED Lighting Solution; Thousands of Facilities in AI-Driven Building Boom Can Benefit from the Customizable Product, Company Says

Written by Customer Service on June 8, 2026. Posted in Public Companies.

MANITOWOC, Wis., June 08, 2026 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced its first customer deployment of its MPHL2 LED Lighting solution. The customized product, introduced to the market a few weeks ago, is able to bring energy efficiency in LED lighting to thousands of data centers. In partnership with Orion’s channel partners, the solution was developed to meet the needs of hyperscale data-centers. The initial order is for a single location, with the expectation that the scope of work will expand over the coming months and years. Orion’s linear lighting fixture is designed specifically to fit the architecture and floor plan of data centers. Made in Orion’s...

Form 8.3 – LondonMetric Property Plc & Schroder REIT Ltd

Written by Customer Service on June 8, 2026. Posted in Mergers And Acquisitions.

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date...

RedCloud Signs Leading Beverage Manufacturer to RedAI; Lagos Deployment Scales to Up to 100,000 Retailers

Written by Customer Service on June 8, 2026. Posted in Public Companies.

Three-month commercial engagement under standard RedAI subscription tiers, with defined upgrade pathway to up to 100,000 retailers; expands the proprietary FMCG dataset training RAID and reinforces RedCloud’s growth trajectory in West Africa London, UK and Lagos, Nigeria, June 08, 2026 (GLOBE NEWSWIRE) — RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”), the technology company building intelligent infrastructure for global trade, today announced the signing of a leading beverage manufacturer (the “Customer”), one of the largest producers and distributors of carbonated soft drinks in the country. Through an initial three-month commercial engagement, the Customer will deploy RedCloud’s RedAI infrastructure across its Lagos route-to-market, under a tier-upgrade structure scaling to up to 100,000 retailers, to unlock...

MACOM Introduces its Hot Via Chip Scale Technology to Eliminate Wire Bonds

Written by Customer Service on June 8, 2026. Posted in Public Companies.

LOWELL, Mass., June 08, 2026 (GLOBE NEWSWIRE) — MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced a chip scale hot via process built on its AlGaAs diode technology. As an alternative to traditional chip and wire bonding and copper pillar-based surface mount technologies, MACOM’s hot via process simplifies surface mount assembly while delivering low insertion loss and high isolation. Hot via technology enables direct surface mount attachment by routing RF signal and ground paths vertically through the die. By removing bond wires, customers can reduce assembly complexity, improve manufacturing consistency and minimize parasitics, thereby achieving high signal integrity and reliable performance into millimeter wave (mmWave) frequencies. “MACOM continues to build on its deep expertise...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals